Literature DB >> 988964

Human pharmacokinetics of sotalol.

M Anttila, M Arstila, M Pfeffer, R Tikkanen, V Vallinkoski, H Sundquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 988964     DOI： 10.1111/j.1600-0773.1976.tb03162.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  28 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects.

Authors:  V H Deneer; L Lie-A-Huen; J H Kingma; J H Proost; J C Kelder; J R Brouwers
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

3.  Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.

Authors:  Jean-Louis Démolis; Soraya Strabach; Françoise Vacheron; Christian Funck-Brentano
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

4.  Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations.

Authors:  R Krapf; M Gertsch
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

5.  Coronary blood flow and hemodynamic effects of beta-adrenoceptor activation and beta-blockade in the baboon.

Authors:  C Rosendorff; G G Rogers; C J Shimell; A Coull; L Bomzon
Journal:  Basic Res Cardiol       Date:  1981 Sep-Oct       Impact factor: 17.165

6.  Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?

Authors:  D B Jack
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

7.  Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.

Authors:  P C O'Connor; J M Arnold; A N Brown; R J Francis; M B Finch; D B Galloway; D W Harron; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

8.  Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.

Authors:  F M Belpaire; M G Bogaert; M Rosseneu
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen; M Anttila; H Sundqvist
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

10.  Comparison of once and twice daily administration of sotalol in the treatment of hypertension.

Authors:  I Parvinen; E Paukkala
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.